Hassan-Alin M - Search Results

1

Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole.

Andersson T, Hassan-Alin M, Hasselgren G, Röhss K, Weidolf L. Andersson T, et al. Among authors: hassan alin m. Clin Pharmacokinet. 2001;40(6):411-26. doi: 10.2165/00003088-200140060-00003. Clin Pharmacokinet. 2001. PMID: 11475467 Review.

2

Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects.

Hassan-Alin M, Andersson T, Bredberg E, Röhss K. Hassan-Alin M, et al. Eur J Clin Pharmacol. 2000 Dec;56(9-10):665-70. doi: 10.1007/s002280000206. Eur J Clin Pharmacol. 2000. PMID: 11214773

3

Pharmacokinetic study of esomeprazole in the elderly.

Hasselgren G, Hassan-Alin M, Andersson T, Claar-Nilsson C, Röhss K. Hasselgren G, et al. Clin Pharmacokinet. 2001;40(2):145-50. doi: 10.2165/00003088-200140020-00006. Clin Pharmacokinet. 2001. PMID: 11286324 Clinical Trial.

4

Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole.

Andersson T, Hassan-Alin M, Hasselgren G, Röhss K. Andersson T, et al. Among authors: hassan alin m. Clin Pharmacokinet. 2001;40(7):523-37. doi: 10.2165/00003088-200140070-00004. Clin Pharmacokinet. 2001. PMID: 11510629 Review.

5

Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole.

Andersson T, Röhss K, Bredberg E, Hassan-Alin M. Andersson T, et al. Among authors: hassan alin m. Aliment Pharmacol Ther. 2001 Oct;15(10):1563-9. doi: 10.1046/j.1365-2036.2001.01087.x. Aliment Pharmacol Ther. 2001. PMID: 11563995 Free article. Clinical Trial.

6

A pharmacokinetic study comparing single and repeated oral doses of 20 mg and 40 mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects.

Hassan-Alin M, Andersson T, Niazi M, Röhss K. Hassan-Alin M, et al. Eur J Clin Pharmacol. 2005 Jan;60(11):779-84. doi: 10.1007/s00228-004-0841-1. Epub 2004 Dec 1. Eur J Clin Pharmacol. 2005. PMID: 15578172 Clinical Trial.

7

Studies on drug interactions between esomeprazole, amoxicillin and clarithromycin in healthy subjects.

Hassan-Alin M, Andersson T, Niazi M, Liljeblad M, Persson BA, Röhss K. Hassan-Alin M, et al. Int J Clin Pharmacol Ther. 2006 Mar;44(3):119-27. doi: 10.5414/cpp44119. Int J Clin Pharmacol Ther. 2006. PMID: 16550734 Clinical Trial.

8

Pharmacokinetic study of esomeprazole in patients with hepatic impairment.

Sjövall H, Björnsson E, Holmberg J, Hasselgren G, Röhss K, Hassan-Alin M. Sjövall H, et al. Among authors: hassan alin m. Eur J Gastroenterol Hepatol. 2002 May;14(5):491-6. doi: 10.1097/00042737-200205000-00005. Eur J Gastroenterol Hepatol. 2002. PMID: 11984146

9

The effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pH.

Junghard O, Hassan-Alin M, Hasselgren G. Junghard O, et al. Among authors: hassan alin m. Eur J Clin Pharmacol. 2002 Oct;58(7):453-8. doi: 10.1007/s00228-002-0502-1. Epub 2002 Sep 3. Eur J Clin Pharmacol. 2002. PMID: 12389067

10

Pharmacokinetics of esomeprazole following varying intravenous administration rates.

Niazi M, Ahlbom H, Bondarov P, Karlsson AH, Hassan-Alin M, Rydholm H, Röhss K. Niazi M, et al. Among authors: hassan alin m. Basic Clin Pharmacol Toxicol. 2005 Dec;97(6):351-4. doi: 10.1111/j.1742-7843.2005.pto_150.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 16364049 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page